New Technology Weighs In On Mammography Debate

Despite proven success in reducing breast cancer mortality, mammography remains one of the most controversial techniques of cancer screening. The recommendation that women aged 50 and older have regular mammograms is universally accepted. But the question over whether women aged 40-49 years should receive regular screenings has sharply divided the medical community. MAMMOGRAPHIC PLOT: Jack Sklansky has developed a method of graphically representing a mammogram, which could improve accuracy. E

Written byStephen Hoffert
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Despite proven success in reducing breast cancer mortality, mammography remains one of the most controversial techniques of cancer screening. The recommendation that women aged 50 and older have regular mammograms is universally accepted. But the question over whether women aged 40-49 years should receive regular screenings has sharply divided the medical community.


MAMMOGRAPHIC PLOT: Jack Sklansky has developed a method of graphically representing a mammogram, which could improve accuracy.
Earlier this year, the National Cancer Institute (NCI) went against the recommendation of the National Institutes of Health when it endorsed biennial mammograms for women under 50 years old. Critics of the decision have charged that NCI and its National Cancer Advisory Board (NCAB) disregarded scientific evidence and gave in to political pressure with the recommendation (S. Glazer, CQ Researcher, 7[24]:555-64, 1997).

The newest studies on the benefits and risks of mammographic screening for the controversial age group could renew the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies